EUVIMEDEUVIMED entdecken
Open Access

Extensive Hypoglycosylation of Serum N‐Glycoproteins in SRD5A3 Deficiency

Anu Jain, Rohit Budhraja, Kishore Garapati iD, Christina Lam iD, Matthew J Schultz, Tamas Kozicz iD, Eva Morava, Akhilesh Pandey iD

Journal of Inherited Metabolic Disease · 2026

DOI: 10.1002/jimd.70163 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Inherited Metabolic Disease, 2026. Verfasst von Anu Jain und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota, USA. Hauptthemen laut MEDLINE: Membrane Proteins, Congenital Disorders of Glycosylation, Glycoproteins, 3-Oxo-5-alpha-Steroid 4-Dehydrogenase. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 67 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: DBT-Wellcome Trust India Alliance, NIH HHS, Mayo Clinic Center for Biomedical Discovery.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Polyprenal reductase is an enzyme encoded by the SRD5A3 gene, which is involved in the synthesis of dolichol from polyprenol. Dolichol serves as a carrier for glycan precursors or monosaccharides in N‐linked glycosylation. Pathogenic variants in SRD5A3 can result in a congenital disorder of glycosylation (CDG), SRD5A3‐CDG, which is inherited in an autosomal recessive manner. Most plasma proteins are glycosylated and changes in the glycosylation of several glycoproteins are associated with pathological consequences. Despite the critical role of SRD5A3 in glycosylation, the impact of its deficiency on the glycosylation of serum proteins remains largely unexplored. In this study, we used tandem mass tag‐based multiplexed quantitative approach to analyze serum N‐glycoproteomics and proteomics in SRD5A3‐CDG patients and controls. We quantified 2200 serum N‐glycopeptides from 359 N‐glycosites from 204 serum proteins. Extensive hypoglycosylation of serum proteins was observed in patients, with 245 of 291 altered glycopeptides decreased in SRD5A3‐CDG. Altered glycopeptides included those derived from haptoglobin, plasma serine protease inhibitor, alpha‐1‐B glycoprotein, alpha‐2‐macroglobulin, and ceruloplasmin. Some of these proteins have previously been reported to be associated with liver dysfunction, anemia, and coagulopathy, which could underlie similar clinical features observed in SRD5A3‐CDG patients. Overall, our study provides novel insights into alterations in the glycosylation status of specific serum proteins in SRD5A3‐CDG. Some of these alterations could be further pursued to develop glycopeptide‐based biomarkers as the current diagnosis of SRD5A3‐CDG by screening assays remains challenging. In addition, knowledge of altered glycoproteins could enhance our understanding of the disease spectrum and potentially unveil additional therapeutic avenues.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Membrane ProteinsCongenital Disorders of GlycosylationGlycoproteins3-Oxo-5-alpha-Steroid 4-DehydrogenaseHumansGlycosylationProteomicsDolicholsTandem Mass Spectrometry

Stichwörter der Autor:innen

Type 1 CDGcomplex glycanspolyprenol reductaserare diseases

Substanzen

Membrane ProteinsGlycoproteins3-Oxo-5-alpha-Steroid 4-DehydrogenaseSRD5A3 protein, humanDolichols

Autor:innen und Institutionen

  • Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota, USA.
  • Manipal Academy of Higher Education (MAHE), Manipal, Karnataka, India.
  • Institute of Bioinformatics, International Technology Park, Bangalore, Karnataka, India.
  • Norcliffe Foundation Center for Integrative Brain Research, Seattle Children's Research Institute, Seattle, Washington, USA.
  • Division of Genetic Medicine, Department of Pediatrics, University of Washington School of Medicine, Seattle, Washington, USA.
  • Biochemical Genetics Laboratory, Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota, USA.

ORCID-Profile: Kishore Garapati, Christina Lam, Tamas Kozicz, Akhilesh Pandey

Förderung

  • DBT-Wellcome Trust India Alliance
  • NIH HHS
  • Mayo Clinic Center for Biomedical Discovery
  • NCI NIH HHS
  • Eunice Kennedy Shriver National Institute of Child Health and Human Development
  • Wellcome Trust
  • NCATS NIH HHS
  • NINDS NIH HHS

Zitieren

APA

Jain, A., Budhraja, R., Garapati, K., Lam, C., Schultz, M. J., Kozicz, T., Morava, E., & Pandey, A. (2026). Extensive Hypoglycosylation of Serum N‐Glycoproteins in SRD5A3 Deficiency. Journal of Inherited Metabolic Disease. https://doi.org/10.1002/jimd.70163

Vancouver

Jain A, Budhraja R, Garapati K, Lam C, Schultz MJ, Kozicz T, et al. Extensive Hypoglycosylation of Serum N‐Glycoproteins in SRD5A3 Deficiency. Journal of Inherited Metabolic Disease. 2026. doi:10.1002/jimd.70163

BibTeX
@article{Jain2026,
  author = {Jain, Anu and Budhraja, Rohit and Garapati, Kishore and Lam, Christina and Schultz, Matthew J and Kozicz, Tamas and Morava, Eva and Pandey, Akhilesh},
  title = {Extensive Hypoglycosylation of Serum N‐Glycoproteins in SRD5A3 Deficiency},
  journal = {Journal of Inherited Metabolic Disease},
  year = {2026},
  doi = {10.1002/jimd.70163}
}
Kostenlos starten →